Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000319823 | SCV000432138 | uncertain significance | Mitochondrial DNA depletion syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000374449 | SCV000432139 | uncertain significance | Mitochondrial DNA depletion syndrome 9 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000997181 | SCV001152373 | uncertain significance | not provided | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000374449 | SCV002141228 | uncertain significance | Mitochondrial DNA depletion syndrome 9 | 2023-12-22 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 320 of the SUCLG1 protein (p.Ser320Asn). This variant is present in population databases (rs146834097, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SUCLG1-related conditions. ClinVar contains an entry for this variant (Variation ID: 337154). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The asparagine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |